The American administrative body for patents, USPTO, communicates registration of the figurative and word marks of the two flagship PharmaNutra […]
PharmaNutra S.p.A. communicates that the Board of Directors has examined and approved the consolidated financial report as at 30th September 2020, […]
PharmaNutra launches a new TV, radio and digital campaign dedicated to the nutrition supplement ApportAL®. ApportAL®, the innovative nutritional supplement […]
Innovative, versatile and easy to apply – available in pharmacies from today – it’s an expansion to the patented Cetylated […]
PharmaNutra S.p.A. informs that the Board of Directors has examined and approved the consolidated interim report on 30th June 2020, […]
The PharmaNutra Group further strengthens its presence outside Europe thanks to a new trade agreement with the Bolivian pharmaceutical company […]
Businesses and universities unite at the Sinergie-SIMA 2020 Conference in an effort to promote change and discuss present and future […]
The IQVIA figures for the first half of 2020 confirm the stability of PharmaNutra leadership in the nutritional supplements sector. […]
After three years since being listed on the AIM Italia Market, PharmaNutra takes stock of the situation: from the industrial […]
PharmaNutra also climbs the annual IQVIA ranking in number of products sold, coming twelfth out of more than 1700 Italian […]
Capricare.it, un nuovo portale dedicato a bambini e mamme, ma che pensa anche ai professionisti del settore sanitario. Junia Pharma […]
Market Insight continues its in-depth study of PharmaNutra S.p.A. through interviews with Chairman and CEO, Roberto Lacorte, and Managing Director, […]
Great investor interest in the Company’s strategies during the virtual edition of the conference organised today by the Italian Stock […]
This has been a particularly symbolic year for PhamaNutra as 2020 marks two important anniversaries for two of the group’s […]
The No Doping Life association assigns the Play Sure Doping Free stamp to Cetilar® and ApportAL® products, and the company […]
Despite the COVID-19 emergency, the PharmaNutra Group is still strengthening its international presence through new trade agreements signed in Romania, […]
The Regatta Organising Committee has officially announced the cancellation due to the health emergency. The sporting event is postponed until […]
The innovative Sucrosomial® Magnesium developed by the PharmaNutra Group is one of the main ingredients of the new Multicentrum MyMAG […]
The Group recorded a significant +15% on the Italian market in the first three months of the current year, thanks […]
The Group obtains approval of the Cetilar® patent in the USA and new prospects unfold for SiderAL® in India thanks to […]
The Board of Directors approves the draft balance sheet and consolidated financial statement as of 31 December 2019. […]
